Key result
99mTc-DI-80B3 SPECT yields ~76% sensitivity and ~91% specificity for diagnosing acute pulmonary embolism versus CT.
Why the study?
Patients with suspected acute PE for whom existing diagnostic methods are nondiagnostic or contraindicated need an additional diagnostic approach, prompting evaluation of the sensitivity and specificity of 99mTc-DI-80B3/SPECT.
Does (99m)Tc-DI-80B3/SPECT accurately detect acute pulmonary embolism in patients with suspected acute PE?
Does (99m)Tc-DI-80B3/SPECT accurately detect acute pulmonary embolism in patients with suspected acute PE?
Answers are grounded in this paper and cite their sources.
(99m)Tc-DI-80B3/SPECT demonstrates acceptable sensitivity and high specificity for diagnosing acute pulmonary embolism, offering a potential contrast-free alternative for diagnosis.
Rationale We report a new method to diagnose acute pulmonary embolism (PE) by single photon emission computerized tomography (SPECT) after administration of 99mTc-labeled anti–D-dimer (DI-80B3) monoclonal antibody Fab′ fragments. This novel technique provides an additional approach to diagnosing PE in patients for whom other methods are nondiagnostic or contraindicated. Objectives We performed a prospective, multicenter study to investigate the sensitivity and specificity of 99mTc-DI-80B3/SPECT in patients with suspected acute PE. Methods Subjects with a moderate to high clinical probability of PE or a positive D-dimer test underwent a PE-protocol contrast-enhanced multidetector thoracic computed tomography (CT) scan as well as 99mTc-DI-80B3/SPECT (0.5 mg 99mTc-DI-80B3 intravenously followed by a thoracic SPECT 2.5 h later). Separate and independent adjudication committees, blinded to clinical data and other test results, interpreted the 99mTc-DI-80B3/SPECT scans (PE detected as foci of abnormally increased 99mTc uptake) and the thoracic CT scans using Prospective Investigation of Pulmonary Embolism Diagnosis II criteria. Measurements and Main Results Of the 52 patients who were enrolled and completed both tests, 42 had both evaluable SPECT scans and thoracic CT scans. Using the criterion standard (thoracic CT scan) there were 21 patients with PE and 21 without. 99mTc-DI-80B3/SPECT had a sensitivity of 76.2% (95% confidence interval, 52.8–91.8%) and a specificity of 90.5% (95% confidence interval, 69.8–98.8%). Treatment-related serious adverse events did not occur. Conclusions 99mTc-DI-80B3/SPECT was sensitive and specific for acute PE in subjects with moderate to high clinical probability of PE or a positive D-dimer test. 99mTc-DI-80B3/SPECT demonstrated an acceptable safety profile and avoids exposure to contrast. Clinical trial NCT00519506 registered with www.clinicaltrials.gov
No takes yet. Share an insight, caveat, or question.
Morris et al. (2011) studied Suspected acute pulmonary embolism (n=52). 99mTc-DI-80B3/SPECT (99mTc-labeled anti-D-dimer Fab' fragments) vs. Contrast-enhanced multidetector thoracic computed tomography (CT) scan was evaluated on Sensitivity and specificity for diagnosing acute pulmonary embolism compared with thoracic CT scan (Sensitivity 76.2%, Specificity 90.5%, 95% CI 52.8-91.8 (sensitivity); 69.8-98.8 (specificity)). 99mTc-DI-80B3/SPECT demonstrated a sensitivity of 76.2% and specificity of 90.5% for diagnosing acute pulmonary embolism compared to thoracic CT.
Synapse has enriched 10 related papers. Consider them for comparative context: